New funding arrangements with National Australia Bank
Filed with ASX · · 2 pages · English
Earlier from Cann
- ODC manufacture permit granted for Mildura
- Evaluation and option agreement with GSK Consumer Healthcare
- Satipharm CBD products get green light from UK FSA
- Mildura facility practical completion & ODC permit granted
- Cann to begin recruitment for CBD phase 3 clinical trial
Later from Cann
- Monthly Activities/Appendix 4C Cash Flow Report
- GMP manufacturing licence granted for Mildura
- Cann releases FY22 results
- Scope of Mildura GMP licence extended
- Chief Executive Officer role update
Follow Cann into a list and get an email when it puts out news.
Follow Cann